Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease.
J Clin Oncol
; 42(29): 3387-3391, 2024 Oct 10.
Article
em En
| MEDLINE
| ID: mdl-39038267
ABSTRACT
COMMENTARY Sharing the burden of low-volume metastatic cancer between ICB and local treatments.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Inibidores de Checkpoint Imunológico
Limite:
Humans
Idioma:
En
Revista:
J Clin Oncol
Ano de publicação:
2024
Tipo de documento:
Article